共 50 条
- [22] State of the art: C3 glomerulopathy and membranoproliferative glomerulonephritis. A consensus NEPHROLOGE, 2015, 10 (04): : 327 - 340
- [23] Design of an Observational, Longitudinal Data Platform of Patients with C3 Glomerulopathy (C3G) and Idiopathic Immune-Complex Membranoproliferative Glomerulonephritis (IC-MPGN) in the United States JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
- [25] Outcome of membranoproliferative glomerulonephritis and C3-glomerulopathy in children and adolescents Pediatric Nephrology, 2018, 33 : 2289 - 2298
- [26] Long-Term Safety and Efficacy of Pegcetacoplan in Patients with C3 Glomerulopathy or Primary Immune-Complex Membranoproliferative Glomerulonephritis: The Long-Term VALE Extension Study JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
- [27] Association of Histologic Parameters with Outcome in C3 Glomerulopathy and Idiopathic Immunoglobulin-Associated Membranoproliferative Glomerulonephritis CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 17 (07): : 994 - 1007
- [28] Characteristics and Outcomes of Immune-Complex Membranoproliferative Glomerulonephritis and C3 Glomerulonephritis in Japan: A Retrospective Analysis of Data from the Japan Renal Biopsy Registry JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 487 - 487
- [30] Autoimmune abnormalities of the alternative complement pathway in membranoproliferative glomerulonephritis and C3 glomerulopathy Pediatric Nephrology, 2019, 34 : 1311 - 1323